Comparing weak, partial, and null blood group antigens’ distribution in the ASPREE and 1KGP3 datasets
| Blood group system . | Phenotype . | RBCeq prediction . | |||||
|---|---|---|---|---|---|---|---|
| ASPREE (n = 2796) . | AFR (n = 661) . | AMR (n = 347) . | EUR (n = 503) . | EAS (n = 504) . | SAS (n = 489) . | ||
| LU | LU:-13 | 0.21 | — | — | 0.40 | — | — |
| H | H+W (saliva) | 0.07 | — | — | — | 19.05 | — |
| FY | Fy(a−b−)* | — | 93.34 | 1.73 | — | — | — |
| KEL | KEL:6,−7 | — | 0.15 | — | — | — | — |
| JK | Jk(a+W) | 0.54 | 4.39 | 4.74 | 1.19 | 16.47 | 8.38 |
| JR | Jr(a+W) | 1.43 | — | 1.73 | 1.19 | 7.94 | 0.61 |
| ABO | A3 | — | 0.15 | — | — | — | — |
| ABO | B3 | 1.65 | 0.15 | — | — | — | — |
| Blood group system . | Phenotype . | RBCeq prediction . | |||||
|---|---|---|---|---|---|---|---|
| ASPREE (n = 2796) . | AFR (n = 661) . | AMR (n = 347) . | EUR (n = 503) . | EAS (n = 504) . | SAS (n = 489) . | ||
| LU | LU:-13 | 0.21 | — | — | 0.40 | — | — |
| H | H+W (saliva) | 0.07 | — | — | — | 19.05 | — |
| FY | Fy(a−b−)* | — | 93.34 | 1.73 | — | — | — |
| KEL | KEL:6,−7 | — | 0.15 | — | — | — | — |
| JK | Jk(a+W) | 0.54 | 4.39 | 4.74 | 1.19 | 16.47 | 8.38 |
| JR | Jr(a+W) | 1.43 | — | 1.73 | 1.19 | 7.94 | 0.61 |
| ABO | A3 | — | 0.15 | — | — | — | — |
| ABO | B3 | 1.65 | 0.15 | — | — | — | — |
AFR, African; AMR, American; EAS, East Asian; EUR, European; SAS, South Asian.
Only for erythroid cells.